secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2024-04-30T23:59:59+00:00
Accession:  0001213900-24-037861
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma raises ~$15M in registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- Sold 21.43M shares and warrants to buy 21.43M shares at $0.70/combined unit.
- Warrants exercisable at $0.75/share from 6 months after issuance, expire in 5 years.
- Gross proceeds ~$15M; net proceeds ~$13.8M after placement agent fees and expenses.
- Proceeds for general corporate purposes, including pre-clinical/clinical development and working capital.
- Offering closed April 30, 2024; H.C. Wainwright acted as exclusive placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024037861/0001213900-24-037861-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024037861/ea0204892-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-037861

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer